NASDAQ · Medical - Instruments & Supplies

The Cooper Companies, Inc. (COO) Stock

$74.23 +2.64% NASDAQ: COO Healthcare

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical.

Valuation

MetricValue
Price$74.23
Market Cap$14.48B
P/E Ratio29.83
P/B Ratio1.40
P/S Ratio2.82
EPS (TTM)$0.00
52-Week High$89.83
52-Week Low$58.89
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.87%
ROA3.64%
ROCE8.29%
Gross Margin64.24%
Operating Margin17.19%
Net Margin9.67%
Debt/Equity0.30
Current Ratio1.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.9B$3.3B$3.6B$3.9B$4.1B
Operating Profit$506.0M$508.0M$533.0M$706.0M$683.0M
Net Profit$2.9B$386.0M$294.0M$392.0M$375.0M
EPS$59.07$1.94$1.48$1.96$1.87
Op Margin17.3%15.3%14.8%18.1%16.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$9.6B$11.5B$11.7B$12.3B$12.4B
Total Liabilities$2.7B$4.3B$4.1B$4.2B$4.2B
Cash$96.0M$138.0M$121.0M$108.0M$111.0M
Borrowings$1.5B$2.8B$2.6B$2.6B$2.8B

Latest News

COO: Lowering target price to $75.00 Argus Research · Jul 15, 2026 Goldman Sachs Adjusts Price Target on Cooper Companies to $63 From $66, Maintains Sell Rating MT Newswires · Jul 14, 2026 2 Momentum Stocks to Consider Right Now and 1 We Turn Down StockStory · Jul 3, 2026 CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure GlobeNewswire · Jun 30, 2026 How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks? Zacks · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$739.0M$692.0M$608.0M$709.0M$796.0M
Investing Cash Flow$-665.0M$-2.1B$-841.0M$-1.2B$-735.0M
Financing Cash Flow$-25.0M$-98.0M$-13.0M$-30.0M$-362.0M
Net Cash Flow$-20.0M$42.0M$-18.0M$-13.0M$3.0M
Free Cash Flow$524.0M$450.0M$215.0M$288.0M$434.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.56
EV / EBITDA13.05
FCF Yield4.20%
Quick Ratio0.79
Interest Coverage6.83
Return 1Y-0.43%
Return 3Y-26.71%
Return 5Y-29.68%

Ownership

Insiders Held0.61%
Institutions Held106.74%
Institutions Float Held107.40%
Institutional HolderSharesReport Date
Blackrock Inc.16,618,1292026-03-31
Vanguard Capital Management LLC12,718,8292026-03-31
T. Rowe Price Investment Management, Inc.9,060,1772026-03-31
State Street Corporation8,768,4192026-03-31
Vanguard Portfolio Management LLC8,721,3312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DOCS $20.99 +2.79% 19.65 $3.93B 0.00%
FMSFresenius Medical Care AG & Co. KGaA $23.69 -1.86% 12.64 $12.72B 3.63%
HOLXHologic, Inc. $76.01 +0.00% 31.28 $16.97B 0.00%
ICLRICON Public Limited Company $180.00 +6.65% 11.92 $13.78B 0.00%
NBIXNeurocrine Biosciences, Inc. $182.83 +3.64% 23.97 $18.38B 0.00%

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.

The Cooper Companies, Inc. is led by CEO Albert G. White, employs 15,000 people, headquartered in San Ramon, US, publicly traded since 1983.

The Cooper Companies, Inc. (COO) stock trades at $74.23 with a market capitalization of $14.48B. The stock is valued at a price-to-earnings (P/E) ratio of 29.83, price-to-book of 1.40, price-to-sales of 2.82. Over the past 52 weeks the stock has ranged between $58.89 and $89.83, and currently trades 17.4% below its 52-week high.

On profitability, The Cooper Companies, Inc. generates a return on equity (ROE) of 4.87%, return on capital employed of 8.29%, an operating margin of 17.19%, a net profit margin of 9.67%.

Official website: www.coopercos.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides